Dec 6, 2013 8:38 AM PST
Recent news surrounding the biotech sector and small cap biotech stocks Xencor Inc (XNCR), Prosensa Holding NV (RNA), Puma Biotechnology Inc (PBYI), Geron Corporation (GERN) and TNI BioTech Inc (TNIB).
Nov 7, 2013 9:59 AM PST
So why is this Company generating all this capital in the stock market today you ask? Well I would assume that the answer would be "imetelstayt".
Oct 16, 2013 9:21 AM PDT
Geron Corporation (Nasdaq:GERN) Shares of GERN surged early in the morning on Wednesday, after the company was initiated with a rating Buy and price target of $6.50 by brokerage firm MLV & Co. GERN recently reported the closing of the transaction to divest...
Jun 27, 2013 6:58 AM PDT
Geron Corporation (NASDAQ:GERN) has hit the gas - time to get on board.
Jan 11, 2013 6:24 AM PST
Geron Corporation (NASDAQ: GERN). California-based BioTime Inc. announced on January 7 that it will buy Geron Corporations human embryonic stem cell (hESC) assets, which includes intellectual property, 400 patents and patent applications, and the first ever...
Dec 10, 2012 11:36 AM PST
Bull in Advantage hereby designates the following companies as part of our Hot Stock Watchlist today. For more top picks every day, be sure to subscribe to our daily reports. Copies of these reports may be found on our blog at: http://bluehorseshoestocks.com...
Dec 10, 2012 10:43 AM PST
Geron Corporation(NASDAQ: GERN) shares gained 21.84% to $1.31 in the morning hour after the company announced positive clinical results from the Phase 2 trial of imetelstat, the company's first-in-class telomerase inhibitor, in patients with essential thrombocythemia...
Sep 10, 2012 9:02 AM PDT
Geron shares are sinking in trading today after the company announced that it is ending its imetelstat breast cancer study.
Sep 10, 2012 7:22 AM PDT
Geron Corporation (NASDAQ:GERN) and Nordion Inc. (NYSE:NDZ) are in the gutter.... time to go fishing.
Aug 30, 2012 7:58 AM PDT
Shares of Sarepta Therapeutics, Geron Corp., and Avanir Pharmaceuticals are among the major gainers in the biotechnology sector in early trading today.